c ebpβ-lip IFNα and β Mediated JCPyV Suppression through C/EBPβ-LIP Isoform c ebpβ-lip drug Increasing intratumor
c ebp lip drug Increasing intratumor C EBP LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer Journal of Experimental & Clinical Cancer Research A screening strategy for Purified anti C EBP beta 3 isoforms C EBP beta, LAP, LIP
Pay in 4 interest-free payments of $5.67 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4


